Ibaraki, Japan

Noriko Orikasa

This inventor holds 2 USPTO granted patents. Top assignee: Agency of Industrial Science and Technology. Active years: 2006-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriko Orikasa. Retrieved from https://idiyas.com/inventor/noriko-orikasa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Noriko Orikasa: Innovator in Heparin-Binding Proteins

Introduction

Noriko Orikasa is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of heparin-binding proteins. With a total of 2 patents, her work has implications for pharmaceutical compositions and protein functionalization.

Latest Patents

Orikasa's latest patents focus on heparin-binding proteins modified with sugar chains. These patents describe a heparin-binding protein that is functionalized by covalently bonding a sugar chain to it. Additionally, she outlines a method for producing this protein and a pharmaceutical composition that contains it as an active ingredient. Furthermore, her work includes a method for functionalizing a natural protein that lacks a sugar chain by covalently bonding a sugar chain to it.

Career Highlights

Throughout her career, Noriko Orikasa has held significant positions, including Director-General of the Agency of Industrial Science and Technology. Her leadership in this role has contributed to advancements in industrial science and technology in Japan.

Collaborations

Orikasa has collaborated with notable colleagues such as Toru Imamura and Masahiro Asada. These partnerships have fostered innovation and research in her field.

Conclusion

Noriko Orikasa's contributions to the field of heparin-binding proteins and her leadership in industrial science highlight her as a key figure in biochemistry. Her innovative work continues to influence pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…